Summary for 9C5P
Entry DOI | 10.2210/pdb9c5p/pdb |
Descriptor | Metallo-beta-lactamase type 2, MAGNESIUM ION, ZINC ION, ... (5 entities in total) |
Functional Keywords | hydrolase |
Biological source | Pseudomonas aeruginosa |
Total number of polymer chains | 1 |
Total formula weight | 26752.68 |
Authors | Fischmann, T.O.,Scapin, G. (deposition date: 2024-06-06, release date: 2024-10-16, Last modification date: 2024-10-30) |
Primary citation | Bennett, F.,Huang, Y.,Dong, S.,Jiang, J.,Hunter, D.,Zhao, Z.,Gu, X.,Scott, J.D.,Tang, H.,Yang, D.,Xiao, L.,Scapin, G.,Fischmann, T.,Mirza, A.,Dayananth, P.,Painter, R.E.,Villafania, A.,Garlisi, C.G.,Zhang, R.,Mayhood, T.W.,Si, Q.,Li, N.,Amin, R.P.,Chen, F.,Bhatt, B.,Regan, C.P.,Regan, H.,Lin, X.,Wu, J.,Leithead, A.,Young, K.,Pasternak, A. Discovery of sulfone containing metallo-beta-lactamase inhibitors with reduced bacterial cell efflux and histamine release issues. Bioorg.Med.Chem.Lett., 114:129989-129989, 2024 Cited by PubMed Abstract: The design, syntheses and antibacterial evaluation of sulfone analogues of previously disclosed metallo-β-lactamase inhibitors (MBLis) are described. The novel derivatives were overall more effective in gram-negative bacterial cell-based assays when combined with imipenem and relebactam. The major contributors to the improved anti-bacterial activity are enhanced enzyme-inhibitor interactions and reduced bacterial cell efflux monitored via an efflux assay involving isogenic Pseudomonas aeruginosa efflux + and efflux - tool strains. PubMed: 39396683DOI: 10.1016/j.bmcl.2024.129989 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.15 Å) |
Structure validation
Download full validation report
